PolyPid plunges 73% after trial disappointment
PolyPid's product for preventing surgical site infection failed to achieve its primary endpoint, although results for one subgroup of patients were more encouraging.
Source: globes.co.il
Gary Leibler News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Gary Leibler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Gary Leibler Today - Breaking & Trending Today
Alpha Tau Announces Resignation of Gary Leibler from its Board of Directors
/PRNewswire/ -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) (Nasdaq: DRTSW), ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer...
Source: prnewswire.com
Alpha Tau Announces Resignation of Gary Leibler from its Board of Directors
/PRNewswire/ -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) (Nasdaq: DRTSW), ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer...
Source: prnewswire.com